Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Twist Bioscience Corp (TWST) vs Ulta Beauty Inc (ULTA) Price & Performance

Twist Bioscience CorpTrade
Ulta Beauty IncTrade

Price performance (Past 24H)

Key statistics

Twist Bioscience Corp vs Ulta Beauty Inc — how do they compare? Twist Bioscience Corp trades at $123.05 (market cap $7.72B), while Ulta Beauty Inc trades at $534.27 (market cap $23.27B). The key difference: Ulta Beauty Inc is far larger — about 3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Ulta Beauty Inc nearer its low. Which is the better fit depends on your goals.

TWSTULTA
Market Cap
$7.72B$23.27B
Sector
HealthConsumer Cyclical
52-Week High
$124.88$706.82
52-Week Low
$24.16$450.75
Enterprise Value
$7.65B$25.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Twist Bioscience Corp

TWST is trading at $124.88, up 7.96% in the last 24 hours, near its pivot point of $121 with resistance at $129. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Revenue growth is robust, with fiscal 2026 Q3 revenue up 23% year-over-year to $118.4 million, but the company remains unprofitable with a net income margin of -31.66% and negative cash flow from operations. Recent news highlights an upsized $300 million public offering and expansion in AI-driven drug discovery.

The outlook for TWST is mixed; bullish analyst sentiment and AI growth potential are offset by persistent losses and high valuation multiples. Investment opportunity lies in sustained revenue expansion and path to profitability, but risks include cash burn, competitive pressures, and execution challenges in scaling operations. The stock's current price exceeds the consensus target of $106.14, suggesting limited near-term upside based on fundamentals.

Ulta Beauty Inc

ULTA Beauty trades at $548.66, down 2.92% on the day, with strong technical momentum indicated by bullish moving averages and key support at $542. Fundamentally, the company maintains robust profitability with 39.33% gross margins and 47.45% ROE, though recent earnings showed mixed results with a Q4 miss. Revenue growth has been consistent, reaching $11.3B in 2025, while analyst sentiment remains positive with 56.53% buy ratings.

The outlook for ULTA remains favorable with a consensus price target of $618.29 offering 12.7% upside potential. Key opportunities include omnichannel expansion and digital growth initiatives, while risks involve margin pressure from rising costs and competitive retail landscape. Institutional ownership trends show continued confidence with recent position increases by major funds.

Returns comparison

Trailing returns across standard periods

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST

About Ulta Beauty Inc

With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.

Read more on ULTA